: Manufacturer of finished garments Issued and paid-up share capital : Baht 30,000,000.- classified into 3,000,000 ordinary shares, with par value of Baht 10 per share Pre-transaction shareholding level : 573,000
The opinions of the Independent Financial Advisor on the connected transaction (For the purpose of translation only) 0 The opinions of the Independent Financial Advisor on the connected transaction by Thai Wacoal Public Company Limited Presented to Shareholders of Thai Wacoal Public Company Limited Prepared by 8 March 2019 This English report of the Independent Financial Advisor’s Opinions has been prepared solely for the convenience of foreign shareholders of Thai Wacoal Public Company Limited...
will affect labor intensive industries such as textiles and garments, apparel, leather products and wooden products and furniture. Businesses operating in these sectors must increase their productivity
THB 2.6B. • Strong performance for Combined PET, given COVID disruption, driven by strong PET demand, higher Integrated PET spread, lower costs, improved PIA margin. • Integrated Oxides & Derivatives
combined capacity of appx. 30,000 tonnes/ annum. Sinterama is vertically integrated from chips to yarns and offers a vast range of colored polyester yarns for the automotive, furnishing, apparel and
business, featuring both house brand – separate by Apparel under brand Inco, Cheval, Sleep Mate, ETC brand, Non- Apparel under brand Cherish, Prim, Rollica, Cushy, etc., and other brand products. The Company
business, featuring both house brand – separate by Apparel under brand Inco, Cheval, Sleep Mate, ETC brand, Non- Apparel under brand Cherish, Prim, Rollica, Cushy, etc., and other brand products. To date
sales volumes plus greater main raw material costs from higher crude oil price and tight market supply. However, the overall spread margin was improved and bring 23.9% gross profit margin comparing to
postponing the public holidays on 13-15 April 2020 during Songkran Festival until the situation concerning the spread of the novel Coronavirus (Covid-19) has improved, in which case the Cabinet will consider